Yixuan Long

Davis Polk advised the joint book-running managers in connection with concurrent SEC-registered offerings by NeoGenomics, Inc. of 4,400,000 shares of its common stock and $175 million…

Davis Polk advised the sales agents in connection with an SEC-registered at-the-market offering by South Jersey Industries, Inc. of shares of its common stock for up to an aggregate…

Davis Polk acted as special product counsel to the representative of the initial purchasers in connection with a Rule 144A offering by Live Nation Entertainment, Inc. of an aggregate…

Davis Polk advised the book-running manager on an SEC-registered offering by Mohawk Capital Finance S.A. of floating-rate notes due 2021. The notes are fully and unconditionally…

Davis Polk is acting as special tax counsel to Pfizer Inc. on the combination of its off-patent branded and generic established medicines business, Upjohn, with Mylan N.V. Under the terms…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the follow-on offering of 8,050,000 shares of common stock of…

Davis Polk advised the sole book-runner in connection with the SEC-registered secondary offering of 10,835,145 shares of common stock of NeoGenomics, Inc. by the selling stockholder, GE…

Davis Polk advised the representatives of the underwriters in connection with an SEC-registered offering by International Flavors & Fragrances Inc. of $1.5 billion aggregate…

Davis Polk advised the representatives of the underwriters in connection with an SEC-registered offering by International Flavors & Fragrances Inc. of €1.1 billion aggregate principal…

Davis Polk advised the representatives of the underwriters in connection with a $1.65 billion SEC-registered offering of 12,667,947 shares of common stock (which included 1,151,632 shares…